4,168
Views
13
CrossRef citations to date
0
Altmetric
Short Communication

Going native: Direct high throughput screening of secreted full-length IgG antibodies against cell membrane proteins

, , &
Pages 1253-1261 | Received 18 Jul 2017, Accepted 14 Sep 2017, Published online: 12 Oct 2017

References

  • Reichert JM. Antibodies to watch in 2015. mAbs. 2015;7:1-8. doi:10.4161/19420862.2015.988944. PMID:25484055.
  • Ecker DM, Jones SD, Levine HL. The therapeutic monoclonal antibody market. mAbs. 2015;7:9-14. doi:10.4161/19420862.2015.989042. PMID:25529996.
  • Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science. 1985;228:1315-7. doi:10.1126/science.4001944. PMID:4001944.
  • Ward ES, Gussow D, Griffiths AD, Jones PT, Winter G. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli. Nature. 1989;341:544-6. doi:10.1038/341544a0. PMID:2677748.
  • Huse WD, Sastry L, Iverson SA, Kang AS, Alting-Mees M, Burton DR, Benkovic SJ, Lerner RA. Generation of a large combinatorial library of the immunoglobulin repertoire in phage lambda. Science. 1989;246:1275-81. doi:10.1126/science.2531466. PMID:2531466.
  • Clackson T, Hoogenboom HR, Griffiths AD, Winter G. Making antibody fragments using phage display libraries. Nature. 1991;352:624-8. doi:10.1038/352624a0. PMID:1907718.
  • Harvey BR, Georgiou G, Hayhurst A, Jeong KJ, Iverson BL, Rogers GK. Anchored periplasmic expression, a versatile technology for the isolation of high-affinity antibodies from Escherichia coli-expressed libraries. Proc Nat Acad Sci U S A. 2004;101:9193-8. doi:10.1073/pnas.0400187101. PMID:15197275.
  • Mazor Y, Van Blarcom T, Iverson BL, Georgiou G. E-clonal antibodies: selection of full-length IgG antibodies using bacterial periplasmic display. Nat Protoc. 2008;3:1766-77. doi:10.1038/nprot.2008.176. PMID:18948976.
  • Boder ET, Wittrup KD. Yeast surface display for screening combinatorial polypeptide libraries. Nat Biotechnol. 1997;15:553-7. doi:10.1038/nbt0697-553. PMID:9181578.
  • Boder ET, Midelfort KS, Wittrup KD. Directed evolution of antibody fragments with monovalent femtomolar antigen-binding affinity. Proc Natl Acad Sci U S A. 2000;97:10701-5. doi:10.1073/pnas.170297297. PMID:10984501.
  • Chen B, Lim S, Kannan A, Alford SC, Sunden F, Herschlag D, Dimov IK, Baer TM, Cochran JR. High-throughput analysis and protein engineering using microcapillary arrays. Nat Chem Biol. 2016;12:76-81. doi:10.1038/nchembio.1978. PMID:26641932.
  • Doerner A, Rhiel L, Zielonka S, Kolmar H. Therapeutic antibody engineering by high efficiency cell screening. FEBS lett. 2014;588:278-87. doi:10.1016/j.febslet.2013.11.025. PMID:24291259.
  • Burden RE, Caswell J, Fay F, Scott CJ. Recent advances in the application of antibodies as therapeutics. Future Med Chem. 2012;4:73-86. doi:10.4155/fmc.11.165. PMID:22168165.
  • Menzel C, Schirrmann T, Konthur Z, Jostock T, Dubel S. Human antibody RNase fusion protein targeting CD30+ lymphomas. Blood. 2008;111:3830-7. doi:10.1182/blood-2007-04-082768. PMID:18230757.
  • Carter T, Sterling-Levis K, Ow K, Doughty L, Hattarki M, Shapira D, Hewish D, Kortt AA, Russell PJ. Biodistributions of intact monoclonal antibodies and fragments of BLCA-38, a new prostate cancer directed antibody. Cancer Immunol, Immunother: CII. 2004;53:533-42. doi:10.1007/s00262-003-0460-1. PMID:14722669.
  • Di Fede G, Bronte G, Rizzo S, Rolfo Cervetto C, Cocorullo G, Gulotta G, Bazan V, Russo A. Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors. Expert Opin Biol Ther. 2011;11:1433-45. doi:10.1517/14712598.2011.594436. PMID:21663530.
  • Bender E, Woof JM, Atkin JD, Barker MD, Bebbington CR, Burton DR. Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture. Hum Antibodies Hybridomas. 1993;4:74-9. PMID:8518367.
  • Liang M, Dubel S, Li D, Queitsch I, Li W, Bautz EK. Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments. J Immunol Methods. 2001;247:119-30. doi:10.1016/S0022-1759(00)00322-7. PMID:11150543.
  • Nelson CD, Palermo LM, Hafenstein SL, Parrish CR. Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies. Virology. 2007;361:283-93. doi:10.1016/j.virol.2006.11.032. PMID:17217977.
  • Mazor Y, Van Blarcom T, Mabry R, Iverson BL, Georgiou G. Isolation of engineered, full-length antibodies from libraries expressed in Escherichia coli. Nat Biotechnol. 2007;25:563-5. doi:10.1038/nbt1296. PMID:17435747.
  • Zhou C, Jacobsen FW, Cai L, Chen Q, Shen WD. Development of a novel mammalian cell surface antibody display platform. mAbs. 2010;2:508-18. doi:10.4161/mabs.2.5.12970. PMID:20716968.
  • Rakestraw JA, Aird D, Aha PM, Baynes BM, Lipovsek D. Secretion-and-capture cell-surface display for selection of target-binding proteins. Protein Eng, Des Sel: PEDS. 2011;24:525-30. doi:10.1093/protein/gzr008.
  • Shaheen HH, Prinz B, Chen MT, Pavoor T, Lin S, Houston-Cummings NR, Moore R, Stadheim TA, Zha D. A dual-mode surface display system for the maturation and production of monoclonal antibodies in glyco-engineered Pichia pastoris. PloS One. 2013;8:e70190. doi:10.1371/journal.pone.0070190. PMID:23875020.
  • Rhiel L, Krah S, Gunther R, Becker S, Kolmar H, Hock B. REAL-Select: full-length antibody display and library screening by surface capture on yeast cells. PloS one. 2014;9:e114887. doi:10.1371/journal.pone.0114887. PMID:25501029.
  • Wilkinson TC, Gardener MJ, Williams WA. Discovery of functional antibodies targeting ion channels. J Biomol Screen. 2015;20:454-67. doi:10.1177/1087057114560698. PMID:25473082.
  • Sun H, Li M. Antibody therapeutics targeting ion channels: are we there yet? Acta pharmacol Sin. 2013;34:199-204. doi:10.1038/aps.2012.202. PMID:23381110.
  • Hutchings CJ, Koglin M, Marshall FH. Therapeutic antibodies directed at G protein-coupled receptors. mAbs. 2010;2:594-606. doi:10.4161/mabs.2.6.13420. PMID:20864805.
  • Mujic-Delic A, de Wit RH, Verkaar F, Smit MJ. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics. Trends Pharmacol Sci. 2014;35:247-55. doi:10.1016/j.tips.2014.03.003. PMID:24690241.
  • Hoogenboom HR, Lutgerink JT, Pelsers MMAL, Rousch MJMM, Coote J, van Neer N, De Bruïne A, Van Nieuwenhoven FA, Glatz JF, Arends JW. Selection-dominant and nonaccessible epitopes on cell-surface receptors revealed by cell-panning with a large phage antibody library. Eur J Biochem. 1999;260:774-84. doi:10.1046/j.1432-1327.1999.00214.x. PMID:10103007.
  • Siva AC, Kirkland RE, Lin B, Maruyama T, McWhirter J, Yantiri-Wernimont F, Bowdish KS, Xin H. Selection of anti-cancer antibodies from combinatorial libraries by whole-cell panning and stringent subtraction with human blood cells. J immunol Methods. 2008;330:109-19. doi:10.1016/j.jim.2007.11.008. PMID:18096183.
  • Wang XX, Cho YK, Shusta EV. Mining a yeast library for brain endothelial cell-binding antibodies. Nat Methods. 2007;4:143-5. doi:10.1038/nmeth993. PMID:17206151.
  • Panagiotou V, Love KR, Jiang B, Nett J, Stadheim T, Love JC. Generation and screening of Pichia pastoris strains with enhanced protein production by use of microengraving. Appl Environ Microbiol. 2011;77:3154-6. doi:10.1128/AEM.00104-11. PMID:21378037.
  • Love KR, Politano TJ, Panagiotou V, Jiang B, Stadheim TA, Love JC. Systematic single-cell analysis of Pichia pastoris reveals secretory capacity limits productivity. PloS One. 2012;7:e37915. doi:10.1371/journal.pone.0037915. PMID:22685548.
  • Love KR, Bagh S, Choi J, Love JC. Microtools for single-cell analysis in biopharmaceutical development and manufacturing. Trends Biotechnol. 2013;31:280-6. doi:10.1016/j.tibtech.2013.03.001. PMID:23582471.
  • El Debs B, Utharala R, Balyasnikova IV, Griffiths AD, Merten CA. Functional single-cell hybridoma screening using droplet-based microfluidics. Proc Natl Acad Sci U S A. 2012;109:11570-5. doi:10.1073/pnas.1204514109. PMID:22753519.
  • Akbari S, Pirbodaghi T. A droplet-based heterogeneous immunoassay for screening single cells secreting antigen-specific antibodies. Lab on a chip. 2014;14:3275-80. doi:10.1039/C4LC00082J. PMID:24989431.
  • Weaver JC, McGrath P, Adams S. Gel microdrop technology for rapid isolation of rare and high producer cells. Nat Med. 1997;3:583-5. doi:10.1038/nm0597-583. PMID:9142132.
  • Powell KT, Weaver JC. Gel microdroplets and flow cytometry: rapid determination of antibody secretion by individual cells within a cell population. Bio/technology. 1990;8:333-7.
  • Tumarkin E, Tzadu L, Csaszar E, Seo M, Zhang H, Lee A, Peerani R, Purpura K, Zandstra PW, Kumacheva E. High-throughput combinatorial cell co-culture using microfluidics. Integr Bio: quantitative biosciences from nano to macro. 2011;3:653-62. doi:10.1039/c1ib00002k. PMID:21526262.
  • Scanlon TC, Dostal SM, Griswold KE. A high-throughput screen for antibiotic drug discovery. Biotechnol Bioeng. 2014;111:232-43. doi:10.1002/bit.25019. PMID:23955804.
  • Dostal SM, Fang Y, Guerrette JC, Scanlon TC, Griswold KE. Genetically enhanced lysozyme evades a pathogen derived inhibitory protein. ACS Chem Biol. 2015;10:1110-7. doi:10.1021/cb500976y. PMID:25607237.
  • Konitzer JD, Pramanick S, Pan Q, Augustin R, Bandholtz S, Harriman W, Izquierdo S. Generation of a highly diverse panel of antagonistic chicken monoclonal antibodies against the GIP receptor. mAbs. 2017;9:536-49. doi:10.1080/19420862.2016.1276683. PMID:28055305.
  • Mettler Izquierdo S, Varela S, Park M, Collarini EJ, Lu D, Pramanick S, Rucker J, Lopalco L, Etches R, Harriman W. High-efficiency antibody discovery achieved with multiplexed microscopy. Microscopy (Oxford, England). 2016;65:341-52. PMID:27107009.
  • Derer S, Bauer P, Lohse S, Scheel AH, Berger S, Kellner C, Peipp M, Valerius T. Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR antibodies. J Immunol. 2012;189:5230-9. doi:10.4049/jimmunol.1202037.
  • Rakestraw JA, Baskaran AR, Wittrup KD. A flow cytometric assay for screening improved heterologous protein secretion in yeast. Biotechnol prog. 2006;22:1200-8. doi:10.1021/bp0600233. PMID:16889399.
  • Yang XD, Jia XC, Corvalan JR, Wang P, Davis CG. Development of ABX-EGF, a fully human anti-EGF receptor monoclonal antibody, for cancer therapy. Crit Rev Oncol/Hematol. 2001;38:17-23. doi:10.1016/S1040-8428(00)00134-7. PMID:11255078.
  • Zhang F, Wang S, Yin L, Yang Y, Guan Y, Wang W, Xu H, Tao N. Quantification of epidermal growth factor receptor expression level and binding kinetics on cell surfaces by surface plasmon resonance imaging. Anal Chem. 2015;87:9960-5. doi:10.1021/acs.analchem.5b02572. PMID:26368334.
  • Haigler H, Ash JF, Singer SJ, Cohen S. Visualization by fluorescence of the binding and internalization of epidermal growth factor in human carcinoma cells A-431. Proc Natl Acad Sci U S A. 1978;75:3317-21. doi:10.1073/pnas.75.7.3317. PMID:356052.
  • Kearns JD, Bukhalid R, Sevecka M, Tan G, Gerami-Moayed N, Werner SL, Kohli N, Burenkova O, Sloss CM, King AM, et al. Enhanced Targeting of the EGFR Network with MM-151, an Oligoclonal Anti-EGFR Antibody Therapeutic. Mol Cancer Ther. 2015;14:1625-36. doi:10.1158/1535-7163.MCT-14-0772. PMID:25911688.
  • Boland WK, Bebb G. Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity. Expert Opin Biol Ther. 2009;9:1199-206. doi:10.1517/14712590903110709. PMID:19624281.
  • Garrido G, Tikhomirov IA, Rabasa A, Yang E, Gracia E, Iznaga N, Fernández LE, Crombet T, Kerbel RS, Pérez R. Bivalent binding by intermediate affinity of nimotuzumab: a contribution to explain antibody clinical profile. Cancer Biol Ther. 2011;11:373-82. doi:10.4161/cbt.11.4.14097.
  • Koskela EV, de Ruijter JC, Frey AD. Following nature's roadmap: folding factors from plasma cells led to improvements in antibody secretion in S. cerevisiae. Biotechnol j. 2017;12(8). doi:10.1002/biot.201600631.
  • Madsen CK, Vismans G, Brinch-Pedersen H. The PARS sequence increase the efficiency of stable Pichia pastoris transformation. J Microbiol Methods. 2016;129:1-7. doi:10.1016/j.mimet.2016.07.015. PMID:27444547.
  • Hamilton SR, Davidson RC, Sethuraman N, Nett JH, Jiang Y, Rios S, Bobrowicz P, Stadheim TA, Li H, Choi BK, et al. Humanization of yeast to produce complex terminally sialylated glycoproteins. Science. 2006;313:1441-3. doi:10.1126/science.1130256. PMID:16960007.
  • Estep P, Reid F, Nauman C, Liu Y, Sun T, Sun J, Xu Y. High throughput solution-based measurement of antibody-antigen affinity and epitope binning. mAbs. 2013;5:270-8. doi:10.4161/mabs.23049. PMID:23575269.